Long-term follow-up outcomes for patients undergoing primary total hip arthroplasty with uncemented versus cemented femoral components: a retrospective observational study with a 5-year minimum follow-up

Table 1 Patient demographics and outcomes

Variable	UTHA^a (n = 160)	CTHA^b (n = 164)	p value
Sex, M/F	97/63	92/72	0.409*^c
Age, years	68.61 ± 7.49	68.75 ± 7.04	0.215*^d
BMI, kg/m²	27.11 ± 7.75	27.36 ± 8.12	0.322*^d
BMD	− 3.59 ± 0.45	− 3.64 ± 0.37	0.176*^d
Side, left/right	86/74	81/83	0.432*^c
Comorbidities, n%			0.296*^e
Hypertension	33 (20.6)	29 (17.7)
Diabetes mellitus	37 (23.1)	38 (23.2)
Cardiopathy	15 (9.4)	17 (10.4)
Hypertension and diabetes mellitus	22 (13.8)	25 (15.2)
Pulmonary	24 (15.0)	26 (15.8)
Cerebrovascular accident	16 (10.0)	20 (12.2)
Anaemia	11 (6.9)	15 (9.1)
Mechanism of injury, n%			0.454*^e
Traffic-related injury	35 (21.8)	38 (23.1)
Injury by falling	89 (55.6)	96 (58.5)
Tamp injury	36 (22.6)	30 (18.4)
ASA Index, n%			0.609*^e
I	45 (28.1)	47 (28.6)
II	76 (47.5)	83 (50.6)
III	39 (24.4)	34 (20.8)
Preoperative HHS	57.82 ± 16.48	57.64 ± 15.88	0.231*^d
Follow-up period (months)	73.16 ± 11.72	73.25 ± 13.58	0.069*^d

UTHA uncemented femoral component total hip arthroplasty, CTHA cemented femoral component total hip arthroplasty, HHS Harris hip score, ASA American Society of Anesthesiologists, BMI body mass index, BMD bone mineral density
*No statistically significant values
^a,bUncemented or cemented femoral component: Stryker Orthopaedics, Mahwah, NJ, USA; acetabular component: standard-device, Stryker Orthopaedics, Mahwah, NJ, USA
^cAnalysed using the chi-square test
^dAnalysed using an independent-samples t test
^eAnalysed using the Mann-Whitney test

ISSN: 1749-799X